Wells Fargo lowered the firm’s price target on Petco to $7 from $11 and keeps an Overweight rating on the shares. While Petco’s Q2 was in line with slightly better comps, the update was “disappointing,” with discretionary sales deteriorating 9% with low visibility into a gross margin bottom, the analyst tells investors in a research note.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on WOOF:
- Petco price target lowered to $8 from $11 at Baird
- Petco Healthcare (NASDAQ: WOOF) Stumbles after Q2 Earnings Drop 62.5%, Future Projections Disappoint
- Petco falls 8% to $6.00 after cutting FY23 EPS guidance
- Petco Health + Wellness Company, Inc. Reports Second Quarter Earnings
- Petco CFO sees shift in consumer spending, pressures on discretionary business